Find uplifting stories about heroes, innovations, and solutions
6878 results for "migraine treatment"
A migraine prevention drug just passed a major test for patients who haven't found relief from existing treatments. After 12 weeks, the intravenous antibody significantly reduced monthly migraine days compared to placebo.
Revolutionary new treatments are transforming life for the billion people worldwide who suffer from migraine. From nerve-stimulating devices to breakthrough medications, patients finally have real options after decades of limited relief.
Groundbreaking therapies are transforming life for migraine patients worldwide, from nerve-zapping devices to targeted medications. After decades of limited options, those suffering from this debilitating condition finally have real relief within reach.
A breakthrough treatment reduces migraine frequency by nearly twice as much as a placebo in children and adolescents, offering hope to young people who've had limited medical options. Almost half of kids using the drug saw their migraine days cut in half.
A biotechnology company has developed elismetrep, a novel drug that works differently from existing migraine treatments and could help the 70% of patients who don't find relief with current options. The drug targets a previously unexplored pathway in pain neurons, offering new hope for millions of migraine sufferers.
A common blood pressure medication helped mice recover from migraine symptoms by boosting the brain's natural cleaning system. The discovery could offer new hope for the one in three migraine patients who don't respond to current treatments.
A groundbreaking UC San Diego study proves low-dose cannabis effectively treats acute migraines, with two-thirds of patients experiencing pain relief within two hours. The placebo-controlled trial offers hope for millions seeking alternatives to traditional migraine medications.
Scientists are revisiting an old pathway for migraine treatment that could help the 1 in 3 patients who don't respond to current medications. New research shows blocking substance P, a pain-triggering molecule, might unlock relief for hundreds of millions of people worldwide.
A Brazilian study found that ear acupuncture helped reduce migraine pain by up to 18% in women suffering from chronic attacks. The research offers hope for the millions who struggle to find relief from conventional treatments alone.
Stanford researchers used brain imaging to identify two biological subtypes of migraine headaches, a breakthrough that could end the guesswork in treating one of the world's leading causes of disability. The discovery may help millions of patients get the right treatment from day one.
A groundbreaking clinical trial proves cannabis can effectively treat acute migraines, offering hope to millions who suffer debilitating attacks. The study found low-dose vaporized cannabis delivered significant pain relief within two hours, with benefits lasting up to 48 hours.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
A groundbreaking study will use advanced imaging to personalize cancer treatment, potentially cutting unnecessary therapy while helping more patients access care. The collaboration could transform how doctors decide when prostate cancer patients have received enough treatment.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
Scientists have enrolled the first patient in a groundbreaking trial to find effective treatments for the deadly Bundibugyo strain of Ebola in the Democratic Republic of Congo. The trial brings hope to a region where more than 1,400 people have been infected since May, with currently no approved treatments available.
Showing 20 of 6878